The U.S. 5th Circuit Court of Appeals rolled back the standards for the abortion pill being available to the public to those set before 2016 until the Supreme Court can review this case. The ruling’s summary reads: “After extensive briefing and oral argument, we hold that the district court’s stay order should be VACATED in part and AFFIRMED in part. We conclude that the Medical Organizations and Doctors’ claim as to the 2000 Approval is likely barred by the statute of limitations. Accordingly, that component of the district court’s order must be VACATED. This means that, until final judgment, Mifeprex will remain available to the public under the conditions for use that existed in 2016.”
The U.S. Court of Appeals for the Fifth Circuit upheld a previous ruling that placed some restrictions on access to the abortion pill mifepristone, according to an order released Wednesday.
The court declined to take the abortion pill mifepristone and its generic version mifeprex completely off the market, despite concerns from pro-life medical professionals that the drugs were harmful to women, according to the order. The court did, however, agree with a decision made in April by U.S. District Court Judge Matthew Kacsmaryk of Texas that the easing of restrictions approved by the FDA in 2016 and 2021 should be halted until further review by the Supreme Court.